Parallax Volatility Advisers
RYTM icon

Parallax Volatility Advisers’s Rhythm Pharmaceuticals RYTM Stock Holding History

Parallax Volatility Advisers’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,700
Closed -$487K – 2062
2024
Q4 		$487K Sell
8,700
-16,300
-65% -$900K ﹤0.01% 1514
2024
Q3 		$1.31M Buy
+25,000
New +$1.2M ﹤0.01% 1281
2022
Q4 		– Sell
-45,300
Closed -$1.11M – 3213
2022
Q3 		$1.11M Buy
+45,300
New +$842K ﹤0.01% 1694

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parallax Volatility Advisers's RYTM Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2018, closing a stake of 1,302 shares — an estimated $38K sold.

Parallax Volatility Advisers first reported a position in RYTM in Q4 2017 and held it in 1 quarter. The position peaked at $38K in Q4 2017. 55 funds tracked by Wall St. Rank hold RYTM as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Rhythm Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,302 Rhythm Pharmaceuticals shares in Q1 2018, an estimated $38K.
  • Parallax Volatility Advisers first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Rhythm Pharmaceuticals position peaked at $38K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.